We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DOCU:NASDAQDocuSign, Inc. Analysis

Data as of 2026-05-24 - not real-time

$49.53

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

DocuSign’s stock is trading just above its short‑term moving averages, with the 20‑day and 50‑day trends still intact but still below the long‑term average, indicating a neutral price stance. The Relative Strength Index sits in the upper‑mid range, suggesting momentum is still positive without being overbought. A bullish MACD crossover reinforces the upside bias, while the price remains comfortably above the identified support zone and below the next resistance level. Trading volume has been on the rise, adding confidence to the technical picture, and the market’s extreme‑greed sentiment further fuels short‑term optimism.
On the fundamentals side, DocuSign continues to deliver strong top‑line growth and exceptionally high gross margins, underscoring the durability of its SaaS model. Operating profitability is solid, backed by robust cash generation and a balance sheet with ample cash and minimal debt. The discounted cash‑flow analysis points to a valuation gap that leaves considerable upside potential. Upcoming fiscal‑quarter earnings and the recent addition of a seasoned board member provide catalysts that could accelerate the growth narrative, making the stock attractive for investors with a longer horizon.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Upcoming earnings announcement could drive volatility
  • Technical indicators show bullish momentum but price is neutral
  • Support level provides downside protection

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation upside relative to discounted cash‑flow estimate
  • Consistent revenue growth and high margins
  • Increasing trading volume indicating growing investor interest

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Strong cash generation and low leverage support financial stability
  • AI‑enhanced agreement platform positions the company for secular growth
  • Strategic board appointment adds experienced leadership for future expansion

Key Metrics & Analysis

Financial Health

Revenue Growth7.80%
Profit Margin9.60%
P/E Ratio33.5
ROE15.77%
ROA4.53%
Debt/Equity9.65
P/B Ratio5.1
Op. Cash Flow$1.2B
Free Cash Flow$1.2B
Industry P/E39.5

Technical Analysis

TrendNeutral
RSI58.5
Support$44.06
Resistance$51.42
MA 20$47.37
MA 50$47.01
MA 200$60.98
MACDBullish
VolumeIncreasing
Fear & Greed Index91.61

Valuation

Fair Value$115.48
Target Price$59.88
Upside/Downside20.90%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta0.69
Volatility44.75%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.